| Mutations in the p53 suppressor gene do not correlate with C-k-ras oncogene mutations in colorectal-cancer. | colorectal, |
| hyperplastic parathyroid cells in nodules have an autonomous proliferation mechanism similar to that of cancer, in which C/EBPb is upregulated and phosphorylated to interact with the oncogenic Ras/MAPK pathway | thyroid, |
| Alterations of the p53 tumor-suppressor gene and ki-ras oncogene in human pancreatic cancer-derived cell-lines with different metastatic potential. | pancreatic, |
| Combined point mutations in codon 12 and 13 of KRAS oncogene in prostate carcinomas. | prostate, |
| [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study]. | thyroid, |
| Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. | pancreatic, |
| Diagnosing peripheral lung cancer: the additional value of the Ras-association domain family 1A gene methylation and Kirsten rat sarcoma 2 viral oncogene homolog mutation analyses in washings in nondiagnostic bronchoscopy. | sarcoma,lung, |
| Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12. | pancreatic, |
| Relationship between expression of ras p21 oncoprotein and mutation status of the K-ras gene in sporadic colorectal cancer patients in Tunisia. | colorectal, |
| Activated Ki-ras proto-oncogene in spontaneously transformed and chemical tumor-derived cell lines related to the mouse lung alveologenic carcinoma. | lung, |
| [A joint study of mutation of the Ki-ras oncogene and overexpression of the Tp53 oncogene in colorectal cancer]. | colorectal, |
| BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study. | colorectal, |
| Gain-of-function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K-ras. | HNSC, |
| Association of point mutation in c-Ki-ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes. | lung, |
| Expression of ras oncogene p21 protein in esophageal squamous cell carcinoma. | esophageal, |
| K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. | lung, |
| Mmp10 is overexpressed in lung tumors induced by either the smoke carcinogen urethane or oncogenic Kras. | lung, |
| Tumor suppressor p16INK4a controls oncogenic K-Ras function in human pancreatic cancer cells. | pancreatic, |
| Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling. | lung, |
| Acute pancreatitis accelerates initiation and progression to pancreatic cancer in mice expressing oncogenic Kras in the nestin cell lineage. | pancreatic, |